GlassScriptPhysician profile
Paiwen Sheen
NPI 1942212139
$1,329.06
in general payments reported to CMS, 2019-2025
12 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $331 · 2022: $100 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $479.65 | 2019-2020 | |
| Gilead Sciences, INC. | $225.00 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $147.81 | 2019-2020 | |
| Davol INC. | $145.38 | 2020 | |
| Hologic Sales and Service, LLC | $128.40 | 2019 | |
| Lupin INC. | $48.65 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.10 | 2019-2020 | |
| Astellas Pharma US INC | $32.87 | 2025 | Veozah |
| Abbott Laboratories | $22.97 | 2025 | Alinity M |
| Therapeuticsmd, INC. | $20.93 | 2020 | |
| Minerva Surgical, INC | $20.02 | 2019 | |
| Convatec INC. | $17.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paiwen Sheen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.